Cargando…
Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?
There is a dire need to discover new targets for Alzheimer's disease (AD) drug development. Decreased neuronal glucose metabolism that occurs in AD brain could play a central role in disease progression. Little is known about the compensatory neuronal changes that occur to attempt to maintain e...
Autores principales: | Griffin, Jeddidiah W. D., Bradshaw, Patrick C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316456/ https://www.ncbi.nlm.nih.gov/pubmed/28261376 http://dx.doi.org/10.1155/2017/5472792 |
Ejemplares similares
-
D-Amino Acids and Cancer: Friends or Foes?
por: Murtas, Giulia, et al.
Publicado: (2023) -
Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?
por: Panfili, Eleonora, et al.
Publicado: (2020) -
Zinc in the Brain: Friend or Foe?
por: Choi, Seunghyuk, et al.
Publicado: (2020) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease
por: Ameen, Aishat O., et al.
Publicado: (2022)